Quick filters
- Amgen Announces Webcast of 2012 Third Quarter Financial Results PR Newswire | Thursday October 18, 2012 4:04PM
- In Buffett’s footsteps: The search for low volatility stocks Globe and Mail | Tuesday October 16, 2012 7:08PM
- Amgen Presents Several Sub-Analyses At ASBMR From The Ongoing Open-Label Extension Study Of The Pivotal Phase 3 Prolia Fracture Trial PR Newswire | Sunday October 14, 2012 5:17PM
- Amgen Appoints Cynthia Patton Senior Vice President And Chief Compliance Officer PR Newswire | Friday October 12, 2012 9:17AM
- Amgen Announces 2012 Fourth Quarter Dividend PR Newswire | Thursday October 11, 2012 9:08AM
- FDA Approves New Indication For Prolia® (Denosumab) For The Treatment Of Bone Loss In Men With Osteoporosis At High Risk For Fracture PR Newswire | Thursday September 20, 2012 6:26PM
- Amgen Names Ray Jordan Senior Vice President, Corporate Affairs PR Newswire | Monday September 10, 2012 4:21PM
- Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference PR Newswire | Monday September 10, 2012 4:04PM
- Amgen To Present At The Morgan Stanley Global Healthcare Conference PR Newswire | Friday September 7, 2012 4:03PM
- Amgen To Present At The Baird Healthcare Conference PR Newswire | Friday August 31, 2012 4:05PM
- Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer PR Newswire | Wednesday August 8, 2012 4:01PM
- Amgen's Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83 PR Newswire | Thursday July 26, 2012 4:04PM
- Amgen Announces 2012 Third Quarter Dividend PR Newswire | Thursday July 19, 2012 4:03PM
- Amgen Completes Acquisition of KAI Pharmaceuticals PR Newswire | Thursday July 5, 2012 4:05PM
- Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals PR Newswire | Tuesday June 12, 2012 4:06PM
- 20th Annual Amgen Award For Science Teaching Excellence Honors Nine Outstanding Teachers PR Newswire | Monday June 11, 2012 4:33PM
- Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE? Trial PR Newswire | Friday June 8, 2012 9:15AM
- Amgen Announces Voting Results of Annual Meeting of Stockholders PR Newswire | Wednesday May 23, 2012 5:05PM
- /C O R R E C T I O N -- Amgen/ PR Newswire | Wednesday May 16, 2012 6:02PM
- Analysis Of Rilotumumab (AMG 102) Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or Gastroesophageal Cancer PR Newswire | Wednesday May 16, 2012 6:01PM
Live Discussion of AMGN on StockTwits